Form 4: Bluejay Diagnostics CEO Receives Stock Grant
Insider Transaction (Form 4)
Indranil Dey, President and CEO and a Director of Bluejay Diagnostics, Inc., received 28,000 shares of common stock on August 17, 2026.
Summary
- Grant/award: acquired 28,000 Common Stock on August 17, 2026; holds 40,522 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Indranil Dey — Director, Officer (President and CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Grant/award | Common Stock | 28,000 | — | — | 40,522 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Grant/award (28,000 shares) |
Keywords
insider transaction, Form 4, BJDX, Bluejay Diagnostics, Inc., neutral, Indranil Dey
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.